Mathilde Jalving
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer survivorship and care
- Cancer-related Molecular Pathways
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments
Papers in
- Oncology 60
- Cancer Immunotherapy and Biomarkers 27
- CAR-T cell therapy research 10
- Cutaneous Melanoma Detection and Management 6
-
- Ovarian cancer diagnosis and treatment 11
- Co-authors
- Steven de JongElisabeth G.E. de VriesEllen C. de HeerJourik A. GietemaAdrian L. HarrisJan J. KoornstraJoop D. LefrandtAnna K.L. Reyners
- Journals
- Annals of Oncology (9 papers)Cancer Research (4 papers)Cancer Treatment Reviews (4 papers)Journal of Nuclear Medicine (4 papers)Clinical Cancer Research (2 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Mathilde Jalving
99 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 1.0k
- Gastroenterology 171
- Cancer Research 439
- Pulmonary and Respiratory Medicine 466
- Molecular Biology 927
Countries citing papers authored by Mathilde Jalving
This map shows the geographic impact of Mathilde Jalving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Jalving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Jalving more than expected).
Fields of papers citing papers by Mathilde Jalving
This network shows the impact of papers produced by Mathilde Jalving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Jalving. The network helps show where Mathilde Jalving may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mathilde Jalving, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 27 | |
| 11 | 2021 | 35 | |
| 12 | 2021 | 3 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 7 | |
| 15 | HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer Hit paper breakdown → | 2020 | 256 |
| 16 | 2020 | 1 | |
| 17 | 2018 | 53 | |
| 18 | 2007 | 19 | |
| 19 | Aspirin enhances TRAIL-induced apoptosis of colon cancer cells | 2006 | 2 |
| 20 | 2005 | 29 |
About Mathilde Jalving
Mathilde Jalving is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 102 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (27 papers), Metabolism, Diabetes, and Cancer (11 papers), Ovarian cancer diagnosis and treatment (11 papers), Melanoma and MAPK Pathways (10 papers), CAR-T cell therapy research (10 papers), Medical Imaging Techniques and Applications (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Cutaneous Melanoma Detection and Management (6 papers). The work is most often cited by research in Oncology (1.0k citations), Gastroenterology (171 citations), Cancer Research (439 citations), Pulmonary and Respiratory Medicine (466 citations) and Molecular Biology (927 citations). Mathilde Jalving has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Steven de Jong, Elisabeth G.E. de Vries, Ellen C. de Heer, Jourik A. Gietema, Adrian L. Harris, Jan J. Koornstra, Joop D. Lefrandt, Anna K.L. Reyners, Rijk O. B. Gans and Jelle Wesseling. Their work appears in journals such as Annals of Oncology, Cancer Research, Cancer Treatment Reviews, Journal of Nuclear Medicine and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.